Suchergebnisse - "Nanshan, Zhong"

PubPharm (37)

1

Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China

in: JMIR Public Health and Surveillance | 2024

von Tingting Xu | Yuehan Chen | Wenzhi Zhan | +34

2

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialResearch in context

in: EClinicalMedicine | 2024

von Yangqing Zhan | Zhengshi Lin | Jingyi Liang | +42

3

Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprintingResearch in context

in: EBioMedicine | 2024

von Tingting Cui | Xiaoling Su | Jing Sun | +16

4

An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models

in: Nature Communications | 2023

von Chun-Kit Yuen | Wan-Man Wong | Long-Fung Mak | +8

5

How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share

in: Frontiers in Public Health | 2022

von Wenfeng Cai | Zifeng Yang | Zifeng Yang | +38

6

SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants

in: Cell Discovery | 2022

von Junxiang Wang | Kaiyi Li | Xinyue Mei | +9

7

Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients: A systematic review and meta-analysis

in: EClinicalMedicine | 2022

von Haopeng Zhi | Xiaolong Ji | Zifan Zhao | +12

8

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants

in: Emerging Microbes and Infections | 2022

von Zhuxiang Zhao | Tingting Cui | Mingzhu Huang | +10

9

Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months

in: EClinicalMedicine | 2022

von Mu Chen | Jingwei Liu | Ping Peng | +13

10

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants

in: Emerging Microbes and Infections | 2022

von Jiaying Zhong | Shuo Liu | Tingting Cui | +6